# Nebulized Dexmedetomidine or Lidocaine for Treatment of Post Dural Puncture Headache in Parturients Undergoing Elective Cesarean Section Under Spinal Anesthesia

> **NCT06607861** · EARLY_PHASE1 · RECRUITING · sponsor: **Minia University** · enrollment: 114 (estimated)

## Conditions studied

- Pain Score (VAS)

## Interventions

- **DRUG:** saline group
- **DRUG:** dexmedetomidine group
- **DRUG:** lidocaine group

## Key facts

- **NCT ID:** NCT06607861
- **Lead sponsor:** Minia University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-06
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06607861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06607861, "Nebulized Dexmedetomidine or Lidocaine for Treatment of Post Dural Puncture Headache in Parturients Undergoing Elective Cesarean Section Under Spinal Anesthesia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06607861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*